EHA 2026

June 13, 2026

The European Hematology Association (EHA) annual congress, will take place on June 11-14, 2026, in Stockholm, Sweden.

Cellectis will be presenting as follows:

Lasme-cel Oral Presentation: Safety and efficacy of UCART22 in heavily pre-treated patients with relapsed or refractory CD22+ B-cell acute lymphoblastic leukemia (B-ALL): results of the Phase 1 BALLI-01 trial

Presenter: Nitin Jain, M.D., Professor of Medicine, Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston (TX)

Session Title: Advances in the treatment of lymphoblastic leukemia

Session Room: K1

Live Session Date and Time: Saturday, June 13 at 5:15 – 6:30pm CET

Eti-cel Poster Presentation: Alemtuzumab exposure and sustained IL-2 drive UCART20x22 expansion and clinical response in adults with relapsed or refractory B-cell non-Hodgkin lymphoma: NATHALI-01 study

Presenter: Professor Emmanuel Bachy, M.D., Ph.D., Department of Clinical Hematology, Lyon Sud Hospital, Lyon, France.

Session: Poster Session 2

Poster Number: 4758

Session Date and Time: Saturday, June 13 at 6:45 - 7:45pm CET